This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $27,953.19 firm fixed-price delivery order is for the supply of Dupixent 300 mg/2 ml pens, with a period of performance through November 2024.
The award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This IDC encompasses critical medical commodities across multiple therapeutic areas, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits.
The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen, as the prime contractor, is responsible for the delivery of the requested products to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions.
Generated 2/18/25, 1:34 PM